SBSelamat Budijitno

Selamat Budijitno

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Selamat Budijitno has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Probiotic and ursodeoxycholic acid combination improves microbial gut dysbiosis and bilirubin levels in cholestatic rats

    by Selamat Budijitno, Aldwin Arwidyardi, Endang S. Lestari, Sigit A. Prasetyo, Muflihaul Mutniroh, Luqman Alwi, Sistiya P. Putra

    Context: Cholestasis is marked by a disturbance in bile flow from the liver and potentially progresses to cirrhosis. Hepatic transplantation is the mainstay of therapy in hepatic cirrhosis, which is a high-cost, time-consuming, and complex procedure. Increasing evidence regarding the major role of gut microbiota in bile acid metabolism has prompted the effort to study probiotics as a potential alternative therapeutic strategy in chronic liver disease. Aims: To explore the effect of probiotic administration on Bifidobacterium, as part of the gut microbiota, and bilirubin levels in mice with cholestasis after biliary duct ligation who received standard ursodeoxycholic acid (UDCA) therapy. Methods: Thirty-five male Sprague Dawley rats were randomly assigned into seven groups: Sham-operated rats as healthy controls, cholestatic rats as negative control, UDCA only, probiotics only, and three groups received UDCA-probiotics on a stratified dose for 21 days. The bile duct ligation (BDL) procedure was used to induce cholestasis. Biochemical analyses were conducted for direct and total bilirubin levels, while Bifidobacterium DNA quantification was assessed with PCR. Results: BDL induces cholestasis, marked by a significant increase in direct and total bilirubin levels. The combination of UDCA-probiotics increased the amount of Bifidobacterium, with the highest dose of probiotics showing the highest amount, and the results were comparable among the other groups. The lowest direct and total bilirubin levels were found in the groups with the highest probiotics dose and UDCA combination. Conclusions: UDCA and probiotic combination significantly improved the amount of Bifidobacterium and bilirubin levels in cholestatic rats.


  • Open Access

    The Effects of Andrographis paniculata Leaf Extract on NF-κB and iNOS Expression in the Heart of Lipopolysaccharide-Induced Septic Rats

    by Johan Eko Saputro, Selamat Budijitno, Nani Maharani, Erlangga Pradipta Harianto, Neni Susilaningsih, Nyoman Suci Widyastiti

    Sepsis is a severe medical condition characterized by an excessive inflammatory response to infection, often leading to organ failure, particularly in the heart. Cardiac dysfunction in sepsis results from multiple mechanisms and significantly worsens patient prognosis. Given the limited therapeutic options for sepsis, there is an urgent need to explore new substances that can help modulate the inflammatory response. This study aimed to evaluate the effects of Andrographis paniculata on transcription factors and proinflammatory cytokines, specifically NF-κB and iNOS. This study used a 100% pure, standardized Andrographis paniculata leaf extract with andrographolide content of 5.68%. The extract was diluted in 1.0% Na-CMC to a total volume of 100 mL and administered orally. A negative control group received 100 mL of 1.0% Na-CMC. Lipopolysaccharide (LPS) was injected intraperitoneally to induce inflammation. Thirty male Wistar rats were randomly divided into five groups (n=6 per group): K1 (positive control), P1 (negative control), P2 (200 mg extract), P3 (400 mg extract), and P4 (500 mg extract). The treatment lasted 21 days, after which histopathological samples were analyzed, and NF-κB and iNOS levels were measured using immunohistochemical staining. All three dosages of Andrographis paniculata extract significantly reduced NF-κB and iNOS expression. The highest dosage group (500 mg) showed the most substantial decrease in expression compared to the other treatment groups. Andrographis paniculata leaf extract effectively reduced NF-κB and iNOS expression in a sepsis-induced animal model, highlighting its potential as an anti-inflammatory agent in sepsis management


  • Open Access

    Stage at Diagnosis of Stomach Cancer Amongst Selected East African Countries: A Mini Systematic Review

    by Cyuzuzo Callixte, Dwi Sutiningsih, Suhartono Suhartono, Selamat Budijitno

    Background: Stomach cancer is one of the leading cause of death globally due to its ability to hide clinical manifestations at early stage. This review was mainly aimed to assess the stage at diagnosis of the stomach malignancy among the selected East African countries.Methods: In this review, we retrieved 61 resources composed of 57 papers and 4 reports that were published between the year of 2005 and 2023, however only 22 papers that satisfy the inclusion criteria were considered.Result: The results revealed of this review disclosed that the stomach cancers are diagnosed at advanced stages, specifically stage III and stage IV and this was found to negatively affects the patients’ clinical outcomes and overall survival rate.Conclusion: The present review concludes that the stomach cancer cases that are diagnosed in the selected East African countries are diagnosed late and recommend early diagnosis, improvement of health facilities and diagnostic modalities and capacity development of the oncologists, cancer focal persons and other health professionals.


  • Open Access

    TYPE 2 DIABETES MELLITUS, ANEMIA, AND HYPERTENSION AS THE RISK FACTORS THAT AFFECT THE INCIDENCE OF METASTATIC BREAST CANCER

    by Elma Elmika, Selamat Budijitno, Ari Suwondo

    Background: Breast cancer is one of the most common gynecologic malignancies in women and the main cause of death in 25% of all cases. The main cause of death from breast cancer is metastases, it is estimated that 5-10% of breast cancers have metastasized at the time of early diagnosis with an advanced stage. Purpose: To analyze the risk factors that influence the incidence of metastases in patients with advanced breast cancer. Methods: This study is an analytic observational study with a cross-sectional design, the number of samples in the study was 120 patients. The inclusion criteria of the study sample were breast cancer patients with advanced stages III and IV in the last five years. Exclusion criteria were incomplete patient medical records. The sampling technique in this study was consecutive sampling. This research was conducted at Ibnu Sina Hospital, Makassar City. The variables analyzed in this study were type 2 diabetes mellitus, anemia, and hypertension which were tested with the chi-square test. Results: The results of this study showed that diabetes mellitus type 2 (p=0.00; Prevalence Rate [PR]=1.79; 95% CI=1.32-2.42) and anemia (p=0.03; Prevalence Rate [PR] = 1.82; 95% CI = 1.61-2.86) is a risk factor that affects the incidence of metastases in patients with advanced breast cancer. While the risk factor that has no effect is hypertension. Conclusion: Type 2 diabetes mellitus and anemia are risk factors that influence the incidence of metastases in breast cancer patients.

  • Open Access

    Effect of Phaleria Macrocarpa Supplementation on Apoptosis and Tumor Growth of C3H Mice With Breast Cancer Under Treatment With Adriamycin–Cyclophosphamide

    by Ignatius Riwanto, Selamat Budijitno, Edi Dharmana, Djoko Handojo, Sigit Adi Prasetyo, Albert Eko, Dicky Suseno, Bondan Prasetyo

    The objective of this study was to know the response of supplementation of Phaleria macrocarpa (PM) to adriamycin-cyclophosphamide (AC) in the treatment of C3H mice with breast cancer. Twenty-four C3H mice, who were successfully inoculated with breast cancer cells, were randomly allocated into 4 groups: without treatment, treated with AC, treated with AC + PM 0.07 mg/d, and treated with AC + PM 0.14 mg/d. The tumor size was measured using millimeter calipers before and 12 weeks after treatment. The tumor, liver, and kidneys were removed and prepared for pathologic examination using imunohistochemistry staining, and the apoptotic index was counted using the terminal deoxynucleotidyl transferase dUTP nick end labeling method. AC reduce the tumor growth significantly (P < 0.001), whereas supplementation of PM, which significantly reduced the tumor growth compared with AC only, was at the 0.14 mg/d dose (P = 0.007). AC increase the apoptotic index significantly (P < 0.001), and supplementation with PM showed that the higher dose increased the apoptotic index. The correlation between the apoptotic index and the diameter of tumor was significantly negative (r = −0.884; P = 0.020). The apoptotic index of the liver and kidney increased significantly in the AC group (P < 0.001 and P = 0.002, respectively); supplementation with PM decreased significantly the high apoptotic index caused by AC. We conclude that PM supplementation has a synergic effect to AC treatment in reducing the tumor growth, by increasing apoptosis, and protects the liver and kidney from damage caused by AC.